Honore Tage
Vanda Pharmaceuticals Inc. · Director
Honore Tage is listed in filings as Director at Vanda Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including sale activity. Recent filings connect the profile to Vanda Pharmaceuticals Inc. (VNDA). The current snapshot covers public activity from Jun 9, 2025 to Jun 8, 2026. Reported amounts are shown as $240.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $241k30k shares | SellFeb 23, 2026 | $8.03 | $5.45 |